Ease of use of tobramycin inhalation powder compared with nebulized tobramycin and colistimethate sodium: a crossover study in cystic fibrosis patients with pulmonary Pseudomonas aeruginosa infection.

Ther Adv Respir Dis · 2017 · PMC5933634 · PMID 28614995

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

Although cough is a common AE with inhaled therapies, 25 , 26 a clear trend was observed in the decreased frequency of post-inhalation cough over time from Cycle 1 to Cycle 2 in the TIP/TIP arm.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.